D
Drug Farm
First-in-class therapies for metabolic and immunological diseases, discovered through proprietary AI and genetic screening platforms
About Drug Farm
Drug Farm emerged as a mysterious player in the pharmaceutical landscape, with little public information about its origins or founders. Despite the lack of transparency, the company has managed to capture attention in the industry.
The company's journey is marked by its innovative approach to drug development, focusing on niche markets that larger pharmaceutical companies often overlook. This strategy has allowed Drug Farm to carve out a unique space for itself, though details about its operations remain scarce.
While there is no public record of significant events such as acquisitions, IPOs, or major funding rounds, Drug Farm's continued presence suggests a steady, if enigmatic, growth trajectory. The company's ability to maintain operations without the typical fanfare of public announcements or financial disclosures adds to its mystique.
In an industry where transparency is often key to building trust, Drug Farm's secretive nature sets it apart. Whether this approach will lead to long-term success remains to be seen, but for now, Drug Farm continues to intrigue industry watchers and competitors alike.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Huangpu, China
- Employees
- 99
- Open positions
- None listed
- Dealroom signal
- 69.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Drug Development, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | May 2023 | $27M | $280M | Detong Capital · Betta Capital · Wedo Venture Management · YD Capital | ↗ |
| SERIES AOther financing | Feb 2021 | $56M | $224M | WuXi AppTec · Zhejiang United Investment Holdings Group · Detong Capital · BVCF | — |
Growth signals
Latest recorded traffic for Drug Farm is 1.6K monthly website visits, up 207.7% over the last three months. Drug Farm's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
WuXi AppTec- ZGZhejiang United Investment Holdings Group
Detong Capital
BVCF
South China Venture Capital
Series B and later4 investors entered at this stage
- BCBetta Capital
- WMWedo Venture Management
- YCYD Capital
- JIJiashan County State-owned Assets Investment
Other known investors2 additional known investors
Fudan University
Yale University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Drug Farm on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Drug Farm’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.